The University of Chicago Header Logo

Connection

Vivek Kaushal to Programmed Cell Death 1 Receptor

Back to Details
This is a "connection" page, showing publications Vivek Kaushal has written about Programmed Cell Death 1 Receptor.
Vivek Kaushal
Connection Strength
0.186
Programmed Cell Death 1 Receptor
  1. Immune checkpoint inhibitors as neoadjuvant therapy in early triple-negative breast cancer: A systematic review and meta-analysis. J Cancer Res Ther. 2022 Oct-Dec; 18(6):1754-1765.
    View in: PubMed
    Score: 0.186
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.